Astronauts who spent up to six months aboard the International Space Station (ISS) experienced no loss of muscle mass or function in their ventricles – the pumping chambers of the heart – largely due to extensive exercise regimens, a new study led by UT Southwestern Medical Center researchers showed.
Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai.
BACKGROUNDHeart failure (HF) is a global health problem characterized by impaired heart function. Cardiac remodeling and cell death contribute to the development of HF. Although treatments such as digoxin and angiotensin receptor blocker dr
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $10.2 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to investigate risk factors for malignant arrhythmias in mitral valve prolapse.
A mobile health intervention using tailored text messages did not improve long-term physical activity levels for patients using smartwatches who enrolled in cardiac rehabilitation.
A team led by researchers at Johns Hopkins Bloomberg School of Public Health and the National Cancer Institute has developed a new algorithm for genetic risk-scoring for major diseases across diverse ancestry populations that holds promise for reducing health care disparities.
After world’s first successful transplant in 2022, also performed at the University of Maryland Medical Center (UMMC), this groundbreaking transplant team performed second pig heart transplant on patient deemed ineligible for traditional heart transplant.
A majority of Americans suffering from heart failure face substantial socioeconomic challenges, researchers at UT Southwestern Medical Center found.
There is already robust evidence that people living with cardiovascular disease are disproportionately affected by poor air quality and extreme temperatures, in large part due to climate change, the greatest threat to human health of the 21st century.
Men who say they have stressful jobs and also feel they exert high efforts for low reward had double the risk of heart disease compared to men free of those stressors, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed American Heart Association journal.
Pregnant women with a history of substance abuse face a dramatically increased risk of death from heart attack and stroke during childbirth when compared with women without history of substance abuse, a new Smidt Heart Institute study shows.
In the 25 years since the Nobel Prize was awarded for discovering the role that nitric oxide (NO) plays in the cardiovascular system, researchers have been racing to learn more about how this mysterious signaling molecule works to repair blood vessels damaged by a heart attack, stroke or other cardiovascular event.
Estudos recentes revelam uma tendência preocupante na saúde cardiovascular dos adultos da comunidade LGBTQ+. Eles apresentam uma pior saúde cardíaca em comparação com os adultos heterossexuais cisgênero. As pessoas da comunidade LGBTQ+ também têm uma maior prevalência de fatores de risco de doença cardiovascular.
A diagnostic test, first offered in the United States at University Hospitals Harrington Heart & Vascular Institute, has now shown through a clinical study to significantly decrease cardiovascular mortality, reduce additional non-invasive heart testing, and increase cath lab efficiency.
FINDINGS UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality. But 10-year conditional survival was similar for biventricular and most single-ventricle CHD patients, and notably better for biventricular CHD patients compared to non-CHD heart transplant recipients.
Researchers at Washington University in St. Louis have developed a new computational approach to removing movement in images of expanding and contracting heart cells and tissues. By computationally removing movement, the algorithm mimics a drug’s action in stopping the heart, without compromising cellular structure or tissue contractility.
The University of Kentucky’s Vice President for Research and leading cardiovascular scientist is being recognized for her foundational work in the field of hypertension with a prestigious award from the American Heart Association (AHA).
“The number of people with obesity is rising in every country across the world. Our study is the first to demonstrate that this increasing burden of obesity is translating into rising heart disease deaths,” said lead study author and cardiologist Zahra Raisi-Estabragh, M.D., a clinical lecturer at the William Harvey Research Institute in London.
The treadmill exercise test with electrocardiogram (ECG), also known as an exercise stress test, is one of the most familiar tests in medicine.
Although hundreds of thousands of patients with atherosclerotic cardiovascular disease (ASCVD) are eligible for high-intensity statin therapy, most are not using the drugs, UT Southwestern Medical Center researchers report.
Agreement aims to improve patient care and outcomes on a global scale
Los investigadores de Cedars-Sinai son líderes en la innovación y el uso del reemplazo valvular aórtico transcatéter (TAVR) con válvulas expandibles con balón. Ahora demuestran que volver a hacer los procedimientos TAVR son seguros y eficaces en comparación con situaciones en las que pacientes con perfiles de riesgo similares se someten al mismo procedimiento por primera vez.
The Ohio State University Wexner Medical Center on Wednesday randomized the first patient in the world in a clinical trial evaluating the effectiveness of a device designed to alleviate heart failure symptoms.
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in which patients with similar risk profiles undergo the same procedure for the first time.
A Binghamton University, State University of New York researcher will lend his data-analysis skills to a landmark study of Latina women funded by the National Institutes of Health.
Your daily dose of omega-3s may not be doing what you think it is. Most fish oil supplements on the market today have labels boasting health benefits that aren’t supported by clinical data, according to a study published in JAMA Cardiology by researchers at UT Southwestern Medical Center.
A study of more than 83,000 questionnaires by women ages 50-79, found more than 25% developed irregular heart rhythms, known as atrial fibrillation, which may increase their risk for stroke and heart failure.
A multi-site, five-year study led by a MedStar Heart & Vascular Institute cardiologist and fellow researchers from across the country have demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM), a disease of the heart muscle and their at-risk family members.
CobiCure Medical Technologies, a non-profit pediatric initiative, part of the Advancium Health Network, announced today its continued commitment to solving the unmet needs in pediatric medical technologies.
A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University’s Victorian Heart Institute and Victorian Heart Hospital.
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
Investigators from the Smidt Heart Institute at Cedars-Sinai are one step closer to helping individuals catch a sudden cardiac arrest before it happens, thanks to a study published today in the peer-reviewed journal The Lancet Digital Health.
Results from a large-scale clinical trial could increase usage of high resolution imaging for guiding interventional coronary procedures
Patients living with one of the UK’s most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found.
Dr. Yoon Ki Joung and Dr. Juro Lee of the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with Prof. Hun-Jun Park and Dr. Bong-Woo Park of the Catholic University of Korea College of Medicine, have developed a new treatment for myocardial infarction that uses nanovesicles derived from fibroblasts with induced apoptosis to modulate the immune response.
Throughout the European Society of Cardiology (ESC) Congress August 25-28, 2023, in Amsterdam, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiology, including some of the most recent and promising breakthroughs in research.
Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at Washington University School of Medicine in St. Louis.
Clopidogrel is a commonly prescribed medication used to prevent further heart attacks after an initial event. It needs to be activated in the body to be effective.
What if we could identify the earliest warning signs of cardiovascular disease from a simple saliva sample? Scientists think they have found a way to do so. Gum inflammation leads to periodontitis, which is linked with cardiovascular disease.
E. Dale Abel, MD, PhD, chair of the Department of Medicine at the David Geffen School of Medicine at UCLA and executive medical director of the UCLA Health Department of Medicine has received the Endocrine Society Fred Conrad Koch Lifetime Achievement Award, the group’s highest honor, recognizing exceptional contributions to the field of endocrinology.
American Heart Association honors UC San Diego Health with multiple awards for its commitment to treating patients with heart disease and stroke.
Parents can be so protective of a child with congenital heart disease they often forget what comes next. When should they start learning to take care of their own condition? Two Penn State Health experts share their views.
Pain one year following a heart attack is common and linked with a higher likelihood of death within the next 8 years, finds new study in the Journal of the American Heart Association.
Arterial stiffness is a novel cause of premature heart damage among adolescents, according to a new follow-up study.
Researchers from the University of California, Irvine have just published a study that projects 93 million U.S. adults that are overweight and obese may be suitable for the 2.4 mg dosage of semaglutide, a weight loss medication known under the brand name Wegovy.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right